Within a mouse design, supplying genetic validation of CRK12:CYC9 for a novel drug goal for trypanosomiasis. Further more, practical characterisation of CRK12 and CYC9 using RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively. , et al CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance https://angelocwohu.mpeblog.com/53872717/guaiapate-an-overview